Riskpilot← Back to searchSign inGet full accessDoc Balasingam AB
ABActiveOrg 5591919153Husabyvägen 25General medical practice activities · NACE 8621Est. 20191-4 employees
Revenue 2025
SEK 829K
+53% vs 2024
EBITDA margin
46.9%
+182% vs 2024
Equity ratio
50.3%
Financial strength
Net profit 2025
SEK 308K
+170% vs 2024
| Revenue | SEK 829K | +53% |
| EBITDA | SEK 389K | +182% |
| Net profit | SEK 308K | +170% |
| Total assets | SEK 716K | +77% |
| Equity | SEK 360K | +115% |
| Employees | — | — |
Legal name
Doc Balasingam AB
Org number
5591919153
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
21 januari 2019
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva sjukvårdsverksamhet, konsultation, forskning och undervisning inom sektorerna hälso- och sjukvård samt därmed förenlig verksamhet. Bolaget ska även äga och förvalta fast och lös egendom, förvaltning av aktier och andelar i andra bolag, uthyrning av lokaler samt därmed förenlig verksamhet.
Address
Husabyvägen 25
Email
arani.balasingam@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 317 | 542 | 829 |
| Staff expenses | — | −0 | −0 | −377 | — |
| EBITDA | −16 | −12 | 289 | 138 | 389 |
| Depreciation & amort. | −0 | — | — | — | −0 |
| EBIT | −16 | −12 | 289 | 138 | 389 |
| Net financials | — | −0 | 1 | 6 | −1 |
| Profit before tax | −16 | −12 | 289 | 144 | 388 |
| Tax | −0 | — | −54 | −30 | −80 |
| Net profit | −16 | −12 | 236 | 114 | 308 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 80 | 47 | 393 | 405 | 716 |
| Equity | 40 | 28 | 264 | 168 | 360 |
| Long-term debt | 0 | — | — | — | 0 |
| Short-term debt | 40 | 19 | 129 | 238 | 355 |
| Total debt | 40 | 19 | 129 | 238 | 355 |
EBITDA margin
46.9%
This company
15.8%
Market median
+197% vs market
20212025
Equity ratio
50.3%
This company
38.2%
Market median
+32% vs market
20212025
Return on equity
85.6%
This company
18.4%
Market median
+365% vs market
20212025
Net profit margin
37.2%
This company
8.1%
Market median
+359% vs market
20212025
Asset turnover
1.16×
This company
1.12×
Market median
+4% vs market
20212025
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doc Balasingam AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arani Balasingam | Board of Directors | 0 companies |
| Radhika Balasingam Åberg | Deputy Board Member | 0 companies |